PATENT CLAIM ANALYSIS

Application Number: 15984146
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "049000"]

Abstract:
The present disclosure provides compositions that include a nanoparticle and a compound that reduces the biological activity of one or more bromodomain and extra-terminal family member (BET) proteins (e.g., a bromodomain inhibitor), and methods of using such compounds to increase retention or storage of vitamin A, vitamin D, and/or lipids by a cell, such as an epithelial or stellate cell.

Claim (Index 11):
The composition of  claim 9 , wherein the VDR agonist is:\n a) vitamin D, a vitamin D precursor, a vitamin D analog, a vitamin D receptor ligand, a vitamin D receptor agonist precursor, or a combination thereof; or b) calcipotriol, 25-hydroxy-D3 (25-OH-D 3 ) (calcidiol); vitamin D3 (cholecalciferol); vitamin D2 (ergocalciferol), 1,\u03b125-dihydroxyvitamin D 3  (calcitriol), or a combination thereof.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 93.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15807424', '14921230', '12772981', '14959105', '14651413']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7827025984197683
- 35 USC 102 Novelty (BERT): 0.551984111698874
- Combined Prediction Score: 0.759630749747679
- Mean Citation Score: 294.6769020000001
- Max Citation Score: 412.19766
- Similarity Product: 344.92207953934906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test